| Literature DB >> 23630519 |
Abstract
Amongst the Closteroviridae, Citrus tristeza virus (CTV) is almost unique in possessing a number of distinct and characterized strains, isolates of which produce a wide range of phenotype combinations among its different hosts. There is little understanding to connect genotypes to phenotypes, and to complicate matters more, these genotypes are found throughout the world as members of mixed populations within a single host plant. There is essentially no understanding of how combinations of genotypes affect symptom expression and disease severity. We know little about the evolution of the genotypes that have been characterized to date, little about the biological role of their diversity and particularly, about the effects of recombination. Additionally, genotype grouping has not been standardized. In this study we utilized an extensive array of CTV genomic information to classify the major genotypes, and to determine the major evolutionary processes that led to their formation and subsequent retention. Our analyses suggest that three major processes act on these genotypes: (1) ancestral diversification of the major CTV lineages, followed by (2) conservation and co-evolution of the major functional domains within, though not between CTV genotypes, and (3) extensive recombination between lineages that have given rise to new genotypes that have subsequently been retained within the global population. The effects of genotype diversity and host-interaction are discussed, as is a proposal for standardizing the classification of existing and novel CTV genotypes.Entities:
Keywords: Citrus tristeza virus; divergence; evolution; genotype; recombination; strain
Year: 2013 PMID: 23630519 PMCID: PMC3632782 DOI: 10.3389/fmicb.2013.00093
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Provenance of CTV isolates used in this study.
| Sequence name | Accession no. | Genotype | Isolation host | Country of origin | Sequencing method | Reference |
|---|---|---|---|---|---|---|
| FL202 | KC517493 | VT | FL, USA | SOLiD 5500xl | This study | |
| FS674 | KC517485 | T36 | FL, USA | SOLiD 5500xl | This study | |
| FS701 | KC517494 | VT | FL, USA | SOLiD 5500xl | This study | |
| KC517489 | T30 | |||||
| KC517486 | T36 | |||||
| FS703 | KC517492 | VT | FL, USA | SOLiD 5500xl | This study | |
| KC517491 | T30 | |||||
| KC517487 | T36 | |||||
| FL278 | KC517490 | T30 | FL, USA | SOLiD 5500xl | This study | |
| FS577 | KC517488 | T36 | FL, USA | SOLiD 5500xl | This study | |
| FS02-2 | EU937519 | VT | FL, USA | Affymetrix microarray | Weng et al. ( | |
| EU937520 | T30 | |||||
| EU937521 | T36 | |||||
| T3 | KC525952 | T3 | FL, USA | Sanger | Hilf et al. (unpublished) | |
| NZ-M16 | EU857538 | T3 | New Zealand | Sanger | Harper et al. ( | |
| T68-1 | JQ965169 | T68 | FL, USA | Sanger | This study | |
| HA16-5 | GQ454870 | Unknown | Unknown | Hawaii, USA | Sanger | Melzer et al. ( |
| NZ-B18 | FJ525436 | T68 | New Zealand | Sanger | Harper et al. ( | |
| CT14A | JQ911663 | T68 | China | Sanger | Unpublished | |
| B165 | EU076703 | T68 | India | Sanger | Roy and Brlansky ( | |
| NZRB-TH28 | FJ525433 | RB | New Zealand | Sanger | Harper et al. ( | |
| NZRB-TH30 | FJ525434 | RB | New Zealand | Sanger | Harper et al. ( | |
| NZRB-M17 | FJ525435 | RB | New Zealand | Sanger | Harper et al. ( | |
| NZRB-M12 | FJ525431 | RB | New Zealand | Sanger | Harper et al. ( | |
| NZRB-G90 | FJ525432 | RB | New Zealand | Sanger | Harper et al. ( | |
| B301 | JF957169 | RB | Puerto Rico | Sanger | Roy et al. (unpublished) | |
| HA18-9 | GQ454869 | RB | Unknown | Hawaii, USA | Sanger | Melzer et al. ( |
| T30 | AY260651 | T30 | Unknown | FL, USA | Sanger | Albiach-Marti et al. ( |
| T385 | Y18420 | T30 | Unknown | Spain | Sanger | Vives et al. ( |
| VT | U56902 | VT | Unknown | Israel | Sanger | Mawassi et al. ( |
| T318A | DQ151548 | VT | Unknown | Spain | Sanger | Ruiz-Ruiz et al. ( |
| Nuaga | AB046398 | VT | Unknown | Japan | Sanger | Suastika et al. ( |
| CT11A | JQ911664 | VT | China | Sanger | Unpublished | |
| AT-1 | JQ061137 | VT | China | Sanger | Unpublished | |
| KPG3 | HM573451 | VT | India | Sanger | Biswas et al. ( | |
| T36 | U16304 | T36 | Unknown | FL, USA | Sanger | Karasev et al. ( |
| T36 (Clone) | AY170468 | T36 | N/A | FL, USA | Sanger | Satyanarayana et al. ( |
| 538 (Clone) | N/A | T36 | FL, USA | SOLiD 5500xl | This study |
Figure 1Maximum parsimony phylogeny of the complete genomes of . Major strains are indicated.
Figure 2Neighbor network reconstruction of the complete genomes of . Major strains groupings are indicated.
Average nucleotide and amino acid between strain identities for the (A) complete genome, (B) ORF1a, (C) p25, and (D) p27 genes.
| RB | T36 | T3 | T68 | T30 | VT | HA16-5 | RB | T36 | T3 | T68 | T30 | VT | HA16-5 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RB | RB | ||||||||||||||
| T36 | 90.9 | T36 | 90.6 | ||||||||||||
| T3 | 81.0 | 80.5 | T3 | 85 | 82.9 | ||||||||||
| T68 | 80.9 | 80.5 | 88.0 | T68 | 90.8 | 90.4 | 83 | ||||||||
| T30 | 82.0 | 81.9 | 90.0 | 86.1 | T30 | 73.1 | 72.9 | 72.6 | 72.6 | ||||||
| VT | 81.2 | 80.8 | 92.4 | 89.9 | 90.3 | VT | 73.2 | 72.9 | 72.7 | 72.9 | 91.2 | ||||
| HA16-5 | 81.8 | 80.3 | 84.0 | 86.2 | 83.5 | 83.8 | HA16-5 | 78.0 | 78.1 | 82.8 | 77.9 | 72.1 | 72.2 | ||
| RB | T36 | T3 | T68 | T30 | VT | HA16-5 | RB | T36 | T3 | T68 | T30 | VT | HA16-5 | ||
| RB | RB | ||||||||||||||
| T36 | 93.9 | T36 | 92.9 | ||||||||||||
| T3 | 92.6 | 92.3 | T3 | 87.9 | 87.8 | ||||||||||
| T68 | 92.6 | 93.0 | 95.1 | T68 | 89.3 | 89.1 | 92.8 | ||||||||
| T30 | 92.4 | 93.1 | 93.1 | 92.6 | T30 | 95.5 | 93.9 | 88.1 | 89.4 | ||||||
| VT | 93.1 | 92.8 | 95.4 | 96.4 | 92.7 | VT | 89.2 | 89 | 93.8 | 96.2 | 89.5 | ||||
| HA16-5 | 93.4 | 92.2 | 91.9 | 91.1 | 91.5 | 92.4 | HA16-5 | 92.5 | 92.0 | 87.5 | 88.5 | 92.1 | 88.4 | ||
Amino acid identities are italicized.
Average nucleotide and amino acid identities within the six major CTV strains, divided by ORF.
| Genome | p13 | p18 | p20 | p23 | p25 | p27 | p61 | p65 | p33 | p6 | ORF1a | ORF1b | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | NT | AA | |
| VT | 96.4 | – | 94.9 | 96 | 96.1 | 95.4 | 97.4 | 98.6 | 96.3 | 96.8 | 96.3 | 97.5 | 96.1 | 98.5 | 96.2 | 97.2 | 97.3 | 98.3 | 95.3 | 95.6 | 96.3 | 95.8 | 96.2 | 95.9 | 97.4 | 98.5 |
| T3 | 95.9 | – | 93.3 | 95 | 93.8 | 94.6 | 94.9 | 96.2 | 91.9 | 90.4 | 94.3 | 98.2 | 90.4 | 97.1 | 92 | 94.7 | 93.6 | 98.3 | 97.5 | 96 | 92.8 | 98 | 97.8 | 97.4 | 97.8 | 98.6 |
| T68 | 94.2 | – | 96.2 | 95.4 | 97.3 | 98.2 | 98.9 | 99.7 | 98.6 | 97.8 | 98.6 | 99.1 | 98.8 | 99 | 98.1 | 97.7 | 98.2 | 99.2 | 97.8 | 97.3 | 100 | 100 | 90.8 | 91.8 | 92.2 | 95.3 |
| T30 | 99.4 | – | 99.6 | 99.7 | 99.3 | 99.4 | 99.4 | 100 | 99.1 | 99 | 99.7 | 99.7 | 99.3 | 99.5 | 99.6 | 99.5 | 99.2 | 99 | 99.5 | 99.2 | 99.6 | 100 | 99.4 | 99.4 | 99.4 | 99.6 |
| RB | 96.2 | – | 94.8 | 93.5 | 95.1 | 94.8 | 95.6 | 97.6 | 95.1 | 94.5 | 96.3 | 97.5 | 95.4 | 97.4 | 96.3 | 95.5 | 97.9 | 98.4 | 96.8 | 95.5 | 97.4 | 96.7 | 95.8 | 95.3 | 97.4 | 98.2 |
| T36 | 99.4 | – | 99.2 | 99.3 | 99.9 | 99.8 | 99.8 | 99.7 | 99.5 | 99.2 | 99.6 | 99.6 | 99.5 | 99.8 | 99.5 | 98.9 | 99.7 | 99.4 | 99.5 | 99.6 | 98.8 | 98.4 | 99.4 | 98.4 | 99.8 | 99.8 |
Positively and negatively selected codons present in CTV ORFs identified by FEL and MEME analysis.
| CTV gene | Fixed effects likelihood model | Mixed effects model of evolution | |||
|---|---|---|---|---|---|
| ORF | No. codons | No. negatively selected sites | No. positively selected sites | Sites with episodic diversifying selection | Lineage specific codon diversification |
| p6 | 51 | 15 (29.4%) | 0 | 0 | |
| p13 | 119 | 36 (29.4%) | 1 (0.8%) | 1 (0.8%) | 6 (RB, T36) |
| p18 | 167 | 41 (24.5%) | 2 (1.7%) | 2 (1.7%) | |
| p20 | 182 | 42 (23.1%) | 0 | 4 (2.2%) | 105 (Florida VT); 115 (T3) |
| p23 | 209 | 41 (19.6%) | 4 (1.9%) | 8 (3.8%) | 3 (T36); 27 (T36) (RB, T30); 29 (RB, T30); 78 (RB, T30); 79 (T36) (RB, T30);177 (RB) |
| p25 | 223 | 57 (25.5%) | 0 | 4 (1.8%) | |
| p27 | 240 | 73 (30.4%) | 1 (0.4%) | 2 (0.8%) | 102 (T36) |
| p33 | 303 | 84 (27.7%) | 2 (0.7%) | 8 (2.4%) | 117 (VT, T68, and T3); 219 (T68); 224 (Florida VT) |
| p61 | 536 | 137 (25.6%) | 8 (1.5%) | 17 (3.2%) | 203 (T30); 333 (RB, T30, and T36); 372 (RB, T30, and T36) |
| p65 | 594 | 178 (29.9%) | 3 (0.5%) | 13 (2.2%) | 412 (T30) |
| ORF1b | 500 | 274 (54.8%) | 5 (1.0%) | 11 (2.2%) | 237 (RB and T36) |
| ORF1a | 3124 | 1469 (47.0%) | 59 (1.8%) | 138 (4.4%) | 7 (T3, RB, T30, T36, T68); 27 (T36, RB); 30 (T68); 39 (T68, T36, RB); 47 (T36, RB); 49 (T36, RB); 52 (T36, RB); 53 (T36, RB) (Asian VT); 62 (T36, RB); 75 (T36, RB, T68); 92 (RB); 95 (T68) (T3, T30); 109 (T30) (T36, RB); 163 (T68, RB, T36); 179 (T3, T30) (T68, RB, T36); 234 (T3, T30) (RB); 238 (T3); 255 (T68, RB, T36); 299 (T3) (T68, RB, T36); 302 (RB) (T68); 310 (RB, T36); 336 (RB, T36); 378 (T30); 442 (T68); 471 (T68); 505 (RB, T36); 548 (T68); 571 (T68); 595 (RB, T36); 660 (T68, RB, T36);661 (T36) (T68); 671 (RB, T36); 694 (RB, T36, T68) (T3); 698 (RB, T36) (T68); 699 (RB, T36) (T3) (T68); 718 (T36, RB); 762 (T36, RB); 767 (T68); 875 (RB, T36); 881 (T68, RB, T36); 884 (T68, T3); 924 (RB); 1003 (T30) (RB, T36); 1075 (T68, RB, T36); 1527 (T3) (T36, RB); 1596 (T36); 1607 (T3, Asian VT); 1660 (T3); 1671 (T3), (T36, RB); 1845 (RB, T36); 1850 (T36); 1995 (RB, T36); 2004 (T30); 2016 (RB, T36); 2026 (T3), (T36, RB); 2030 (Asian VT) (T36, RB); 2039 (RB, T36); 2043 (RB); 2073 (Asian VT) (T3) (T36, RB); 2093 (RB, T36); 2103 (RB, T36); 2125 (RB, T36); 2129 (RB, T36); 2143 (T30) (RB, T36); 2168 (T3); 2173 (T30, T36); 2329 (T30); 2381 (T30); 2384 (T3, T30); 2397 (T30) (RB, T36); 2428 (RB, T36); 2464 (T30); 2526 (RB, T36); 2656 (T36, RB); 2683 (RB, T36); 2785 (RB, T36); 2852 (T68) |
Location of strain-specific codon diversification given, per ORF.
Figure 3Frequency of episodic diversifying selection events in ORF1a within CTV lineages as determined by MEME analysis, mapped on to a neighbor-joining nucleotide phylogeny. CTV strains and subtypes indicated.
Positively and negatively selected codons present within recognized domains of ORF1a identified by FEL and MEME analysis.
| Domain | Sites | Amino acid identity (%) | No. residues | No. negatively selected sites | No. positively selected sites | |
|---|---|---|---|---|---|---|
| FEL | MEME | |||||
| L1 | 1–338 | 82.5 | 338 | 112 (33.1%) | 14 (4.1%) | 36 (10.7%) |
| 339–485 | 91.3 | 146 | 63 (43.2%) | 2 (1.4%) | 6 (4.1%) | |
| 486–831 | 74.7 | 345 | 132 (38.3%) | 11 (3.2%) | 30 (8.7%) | |
| L2 | 832–977 | 86.2 | 145 | 79 (54.5%) | 0 | 7 (4.8%) |
| 978–1039 | 89.2 | 61 | 39 (63.9%) | 0 | 1 (1.6%) | |
| MET | 1040–1349 | 93.6 | 309 | 174 (56.3%) | 1 (0.3%) | 4 (1.3%) |
| 1350–2701 | 79.8 | 1351 | 609 (45.1%) | 26 (1.9%) | 71 (5.3%) | |
| HEL | 2702–3099 | 92.2 | 397 | 263 (66.2%) | 3 (0.8%) | 7 (1.8%) |
| 3100–3124 | 83.3 | 24 | 0 | 3 (12.5%) | 4 (16.7%) | |
Strain-specific co-evolution events between recognized domains of ORF1a identified by MirrorTree.
| L1 | L2 | MET | HEL | |||||
|---|---|---|---|---|---|---|---|---|
| L2 | Overall | 0.862 | ||||||
| VT | 0.184 | |||||||
| MET | Overall | 0.884 | Overall | 0.89 | ||||
| T30 | 0.111 | |||||||
| HEL | Overall | 0.847 | Overall | 0.972 | Overall | 0.927 | ||
| T30 | 0.732 | T30 | 0.722 | T30 | 0.45 | |||
| VT | −0.196 | VT | 0.751 | |||||
| RDRP | Overall | 0.865 | Overall | 0.765 | Overall | 0.92 | Overall | 0.832 |
| RB and T36 | 0 | RB and T36 | 0 | RB and T36 | 0 | RB and T36 | 0 | |
| T30 | −0.397 | T30 | 0.668 | |||||
| VT | −0.556 |
Events with a Pearson’s correlation coefficient of 0.8 or higher were considered to be significant (highlighted in bold).
Location and provenance of recombination events present in CTV isolates examined in this study.
| Recombinant isolate | Start | End | Parental strain 1 | Parental strain 2 | RDP | Geneconv | BootScan | MaxChi | Chimera | SiSscan | 3Seq |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M17/TH30 | 111 | 3281 | T36 | RB | 5.64E-47 | 6.46E-24 | 6.92E-29 | 1.09E-31 | 7.88E-29 | 1.47E-81 | |
| B165, NZ-B18 | 3949 | 8305 | VTs | T68 | 1.25E-05 | 3.18E-04 | 8.65E-06 | 2.72E-40 | |||
| CT14A | 5229 | 9390 | Asian VTs | T68 | 1.98E-210 | 7.77E-197 | 1.29E-102 | 1.63E-68 | 2.91E-68 | 2.63E-90 | 1.55E-316 |
| B165 | 607 | 1012 | VTs | T68 | 2.33E-56 | 7.77E-54 | 1.40E-15 | 5.33E-15 | 6.40E-15 | 3.66E-27 | |
| AT-1 | 393 | 3489 | VTs | Asian VTs | 3.22E-25 | 1.70E-30 | 1.33E-16 | 9.30E-24 | 3.59E-17 | 3.38E-14 | 6.22E-49 |
| RB | 12175 | 13809 | VTs | T30 | 1.69E-14 | 9.47E-14 | 2.07E-14 | 4.07E-16 | 6.78E-17 | 9.21E-26 | |
| NZ-B18 | 13154 | 13605 | RB | T68 | 6.46E-18 | 5.55E-16 | 9.67E-12 | 6.39E-05 | 6.17E-05 | 3.21E-04 | |
| CT14A | 16667 | 17410 | VT | T3 | 7.75E-12 | 1.21E-07 | 4.13E-07 | 1.20E-04 | 2.65E-05 | 2.56E-04 | |
| NZ-M16 | 36 | 11532 | VT | T3 | 2.82E-98 | 1.99E-85 | 7.43E-88 | 4.78E-40 | 8.65E-05 | 2.10E-43 | 5.70E-158 |
| HA16-1 | 21 | 11281 | HA18-9 | T68-1 | 1.84E-317 | 3.84E-303 | 3.43E-42 | 1.12E-54 | 9.18E-74 | 5.78E-218 | |
| Asian VTs | 4368 | 5695 | T30 | VTs | 6.60E-04 | 1.25E-02 | 9.71E-08 | 4.29E-08 | 2.81E-08 | 2.20E-02 | |
| T68-1 | 7 | 10848 | Unknown (itself?) | VTs | 7.44E-160 | 7.08E-90 | 2.17E-66 | 1.39E-46 | 4.01E-46 | 1.00E-34 | 6.53E-168 |
| Kpg3 | 10804 | 14424 | T3 | VTs | 4.31E-52 | 6.31E-37 | 1.17E-37 | 5.04E-27 | 6.46E-29 | 6.67E-29 | 4.56E-75 |
| Kpg3 | 14858 | 16000 | T3 | VTs | 8.65E-24 | 2.50E-16 | 3.28E-26 | 1.10E-09 | 1.47E-09 | 2.35E-11 | 3.30E-27 |
| Kpg3 | 17438 | 18040 | T3 | VTs | 1.61E-08 | 2.03E-03 | 7.09E-09 | 6.19E-03 | |||
| HA18-9 | 15781 | 17434 | VT | NZRB-TH28 | 1.63E-85 | 7.03E-64 | 2.66E-86 | 1.87E-13 | 8.29E-08 | 4.25E-18 | 4.61E-26 |
Figure 4Location and origin of the recombination events present in CTV isolates examined in this study, divided by strain.